Showing results (161-170 of 271) with videos related to
Sort By:
Pageof 28
JAMA Cardiology|September 28, 2019
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled StudyGregg W Stone, Takeshi Kimura, Runlin Gao, et al.JACC. Cardiovascular Interventions|May 26, 2009
Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarctionMehdi H Shishehbor, Reza Amini, Leonardo P J Oliveria, et al.Journal of the American College of Cardiology|October 14, 2008
Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortalityMehdi H Shishehbor, Sachin S Goel, Samir R Kapadia, et al.Circulation. Cardiovascular Imaging|March 26, 2021
Implementation of a Myocardial Perfusion Imaging Risk Algorithm to Inform Appropriate Downstream Invasive Testing and TreatmentAnirudh Kumar, Divyang R Patel, Serge C Harb, et al.European Heart Journal|June 17, 2008
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trialStephen G Ellis, Charles D O'Shaughnessy, Steven L Martin, et al.The American Journal of Cardiology|July 20, 2002
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)Jeffrey W Moses, Issam Moussa, Martin B Leon, et al.Journal of the American College of Cardiology|February 19, 2008
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trialsAjay J Kirtane, Stephen G Ellis, Keith D Dawkins, et al.The American Journal of Cardiology|August 19, 2007
Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI)Esteban Escolar, Gary S Mintz, Jeffrey Popma, et al.The American Journal of Cardiology|May 3, 2011
Comparison of outcomes of unprotected left main versus multivessel coronary artery interventionsShikhar Agarwal, Tarique Zaman, E Murat Tuzcu, et al.JACC. Cardiovascular Interventions|December 27, 2016
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic SubstudyDean J Kereiakes, Stephen G Ellis, Takeshi Kimura, et al.Pageof 28